Single-dose clinical pharmacokinetic studies of gefitinib von SWAISLAND, Helen C, SMITH, Robert P, LAIGHT, Alison, KERR, David J, RANSON, Malcolm, WILDER-SMITH, Clive H, DUVAUCHELLE, Thierry

Volltext

Exploring the relationship between expression of cytochrome P450 enzymes and gefitinib pharmacokinetics von SWAISLAND, Helen C, CANTARINI, Mireille V, FUHR, Rainard, HOLT, Alison

Volltext

Pharmacokinetic drug interactions of gefitinib with rifampicin, itraconazole and metoprolol von SWAISLAND, Helen C, RANSON, Malcolm, SMITH, Robert P, LEADBETTER, Joanna, LAIGHT, Alison, MCKILLOP, David, WILD, Martin J

Volltext

ZD1839, a Selective Oral Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor, Is Well Tolerated and Active in Patients With Solid, Malignant Tumors: Results of a Phase I Tri... von RANSON, Malcolm, HAMMOND, Lisa A, FEYEREISLOVA, Andrea, SWAISLAND, Helen, ROWINSKY, Eric K, FERRY, David, KRIS, Mark, TULLO, Andrew, MURRAY, Philip I, MILLER, Vince, AVERBUCH, Steve, OCHS, Judy, MORRIS, Charles

Volltext

Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers von Fong, Peter C, Boss, David S, Yap, Timothy A, Tutt, Andrew, Wu, Peijun, Mergui-Roelvink, Marja, Mortimer, Peter, Swaisland, Helen, Lau, Alan, O'Connor, Mark J, Ashworth, Alan, Carmichael, James, Kaye, Stan B, Schellens, Jan H.M, de Bono, Johann S

Volltext

A first-in-human Phase I dose-escalation trial of the novel therapeutic peptide, ALM201, demonstrates a favourable safety profile in unselected patients with ovarian cancer and oth... von El Helali, Aya, Plummer, Ruth, Jayson, Gordon C., Coyle, Vicky M., Drew, Yvette, Mescallado, Nerissa, Harris, Noor, Clamp, Andrew R., McCann, Janine, Swaisland, Helen, Kennedy, Richard D., Cranston, Aaron N., Wilson, Richard H.

Volltext

Pharmacokinetics and tolerability of the orally active selective epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in healthy volunteers von SWAISLAND, Helen, LAIGHT, Alison, STAFFORD, Lesley, JONES, Helen, MORRIS, Charles, DANES, Aaron, YATES, Roger

Volltext

A sensitive assay for ZD1839 (Iressa ) in human plasma by liquid–liquid extraction and high performance liquid chromatography with mass spectrometric detection: validation and use... von Jones, H.K, Stafford, L.E, Swaisland, H.C, Payne, R

Volltext

A first-in-man phase I tolerability and pharmacokinetic study of the cyclin-dependent kinase-inhibitor AZD5438 in healthy male volunteers von CAMIDGE, D. Ross, SMETHURST, Dominic, GROWCOTT, Jim, BARRASS, Nigel C, FOSTER, John R, FEBBRARO, Salvatore, SWAISLAND, Helen, HUGHES, Andrew

Volltext

A Sensitive and Robust Ultra HPLC Assay with Tandem Mass Spectrometric Detection for the Quantitation of the PARP Inhibitor Olaparib (AZD2281) in Human Plasma for Pharmacokinetic A... von Roth, Jeffrey, Peer, Cody, Mannargudi, Baskar, Swaisland, Helen, Lee, Jung-Min, Kohn, Elise, Figg, William

Volltext